- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Caplin Point Laboratories Limited — Updates, 27-01-2026: Press Release
27-01-2026 | 04:03 pm
27-01-2026 | 04:03 pm
Caplin Steriles received USFDA approval for Methylprednisolone Acetate Injectable Suspension. This generic product enters a US market with approximately $57.4 million in annual sales, indicating significant revenue potential for the subsidiary.
No comments yet. Be the first to comment!